摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(1,4-dioxa-8-azaspiro<4.5>dec-8-yl)-4'-fluorobutyrophenone | 51787-84-9

中文名称
——
中文别名
——
英文名称
4-(1,4-dioxa-8-azaspiro<4.5>dec-8-yl)-4'-fluorobutyrophenone
英文别名
1-(4-fluorophenyl)-4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)butan-1-one;4-(1,4-dioxa-8-azaspiro[4.5]dec-8-yl)-1-(4-fluorophenyl)butan-1-one;4-(1,4-dioxa-8-aza-spiro[4.5]dec-8-yl)-1-(4-fluoro-phenyl)-butan-1-one;8-<3-(4-fluorobenzoyl)propyl>-1,4-dioxa-8-azaspiro-<4,5>-decan;4-(1,4-Dioxa-8-azaspiro[4.5]decan-8-yl)-1-(4-fluorophenyl)butan-1-one
4-(1,4-dioxa-8-azaspiro<4.5>dec-8-yl)-4'-fluorobutyrophenone化学式
CAS
51787-84-9
化学式
C17H22FNO3
mdl
——
分子量
307.365
InChiKey
WUERPSUXLDFSOM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    22
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    38.8
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-(1,4-dioxa-8-azaspiro<4.5>dec-8-yl)-4'-fluorobutyrophenone三氟化硼乙醚 盐酸 作用下, 以 1,4-二氧六环甲醇 为溶剂, 反应 3.0h, 生成 1-<4,4-ethylenedithio-4-(4-fluorophenyl)butyl>-4-piperidinone
    参考文献:
    名称:
    Synthesis of Haloperidol Ethanedithioketal HIV-1 Protease Inhibitors: Magnesium Chloride Facilitated Addition of Grignard Reagents
    摘要:
    作为HIV-1蛋白酶抑制剂的有趣的羟哌啶酮酮缩醇和对苯二甲硫酮,通过将有机锂和有机镁试剂添加到已经含有酮缩醇或硫酮功能的酮前体来合成。向含有硫酮的酮中添加Grignard试剂的反应显著增强,而对含有酮缩醇的酮则适度增强,这是通过添加氯化镁实现的。氯化镁的影响归因于它竞争性地防止Grignard试剂的螯合和从4-氧哌啶环上的质子抽取。酮缩醇和硫酮的生物活性表明,硫酮功能比酮缩醇功能具有更强的抑制HIV-1蛋白酶的能力。
    DOI:
    10.1055/s-1993-25946
  • 作为产物:
    参考文献:
    名称:
    Neurotropic and psychotropic agents. LXVII. 1-[4,4-Bis(4-fluorophenyl)butyl]-4-hydroxy-4-(3-trifluoromethyl-4-chlorophenyl)piperidine and related compounds: New synthetic approaches
    摘要:
    DOI:
    10.1135/cccc19733879
点击查看最新优质反应信息

文献信息

  • <sup>18</sup>F-Labeled 1,4-Dioxa-8-azaspiro[4.5]decane Derivative: Synthesis and Biological Evaluation of a σ<sub>1</sub> Receptor Radioligand with Low Lipophilicity as Potent Tumor Imaging Agent
    作者:Fang Xie、Ralf Bergmann、Torsten Kniess、Winnie Deuther-Conrad、Constantin Mamat、Christin Neuber、Boli Liu、Jörg Steinbach、Peter Brust、Jens Pietzsch、Hongmei Jia
    DOI:10.1021/acs.jmedchem.5b00593
    日期:2015.7.23
    We report the syntheses and evaluation of series of novel piperidine compounds with low lipophilicity as σ1 receptor ligands. 8-(4-(2-Fluoroethoxy)benzyl)-1,4-dioxa-8-azaspiro[4.5]decane (5a) possessed high affinity (Ki = 5.4 ± 0.4 nM) for σ1 receptors and selectivity for σ2 receptors (30-fold) and the vesicular acetylcholine transporter (1404-fold). [18F]5a was prepared using a one-pot, two-step labeling
    我们报告低亲脂性系列新颖的哌啶化合物作为σ的合成和评价1受体配体。8-(4-(2-氟乙氧基)苄基)-1,4-二氧杂-8-氮杂螺[4.5]癸烷(5A)具有高亲和力(ķ我= 5.4±0.4纳米)为σ 1个受体和选择性σ 2受体(30倍)和水泡乙酰胆碱转运蛋白(1404倍)。[ 18 F] 5a是在自动合成模块中使用一锅,两步标记程序制备的,放射化学纯度> 95%,比活度为25-45 GBq /μmol。细胞结合,生物分布和放射自显影与阻断实验表明[18 F]图5a到σ 1种受体在体外和体内。使用小鼠肿瘤异种移植模型的小动物正电子发射断层扫描(PET)成像显示在人类癌和黑色素瘤中高积累。氟哌啶醇的治疗显着减少了放射性示踪剂在肿瘤中的积累。这些结果表明与合适的亲脂性和适当的亲合力放射性示踪剂为σ 1个受体可用于肿瘤成像。
  • Spiro[1,2,4-benzotriazine-3(4H),4′-(1′-substituted)piperidines] and related compounds as ligands for sigma receptors
    作者:Federica Novelli、Fabio Sparatore
    DOI:10.1016/s0014-827x(02)01293-4
    日期:2002.11
    As analogues of some conformationally restricted spiropiperidine derivatives which are endowed with high affinity for sigma(1), receptor, a set of 16 spiro[1,2,4-benzotriazine-3(4H),4'-(1'-substituted)piperidines] and congeneric compounds was prepared and tested for affinity to a, receptor subtype. All N-arylalkyl substituted derivatives exhibited high affinity for the relevant receptor, with K-i in the low nanomolar range. Affinity for sigma(2) subtype (assayed only for a few representative compounds) was from one to three order of magnitude lower. Spiro[ 1,2,4-benzotriazine-3(4H),4'-(1'-benzyl)piperidine] (2), with a ratio K(i)sigma(2)/K(j)sigma(1) = 7000 should represent the most selective sigma(1), ligand so far described. (C) 2002 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
  • Bioisosteric Replacement Leading to Biologically Active [2.2]Paracyclophanes with Altered Binding Profiles for Aminergic G-Protein-Coupled Receptors
    作者:Marika Skultety、Harald Hübner、Stefan Löber、Peter Gmeiner
    DOI:10.1021/jm100899z
    日期:2010.10.14
    Exploring the chemical diversity space of GPCR ligands, we recently discovered [2.2]paracyclophanes as valuable atypical bioisosteres for secondary affinity and selectivity generating moieties. In find out if such an exchange also works for structural moieties that simulate the endogenous neurotransmitter, pi 1 or pi 2 or both systems pi 1 and pi 2 of three representative privileged structures of types 1, 2. and 3 were replaced by a [2.2]paracyclophane unit. Contributions of the respective functionalities to the binding at of a panel of relevant monoaminergic GPCRs were systematically examined. The study led to the paracyclophanylpiperazine 3a displaying excellent D-3 affinity (K-i = 1.6 nM) and a strongly attenuated binding to D-4, 5-HT1 and alpha(1). Whereas functional experiments showed neutral D-3 antagonist properties, mutagenesis studies indicated a binding mode that is similar to its lead compounds of type 3.
  • Novelli; Sparatore, Il Farmaco, 1996, vol. 51, # 8-9, p. 541 - 550
    作者:Novelli、Sparatore
    DOI:——
    日期:——
  • Sui Zhihua, De Voss James J., DeCamp Dianne L., Li Jia, Craik Charles S.,+, Synthesis, (1993) N 8, S 803- 808
    作者:Sui Zhihua, De Voss James J., DeCamp Dianne L., Li Jia, Craik Charles S.,+
    DOI:——
    日期:——
查看更多